Advice for pharmacists assisting patients with allergic rhinitis
Individuals with allergic rhinitis (AR) will often seek relief with the use of over-the-counter therapies from pharmacies. 1A recent article published online by Pharmacy Times has highlighted how pharmacists can offer guidance to patients when selecting appropriate treatment strategies for AR. 1
Therapy selection
In order for optimal treatment choices to be made, it is important for pharmacists to explain key differences between AR treatments. 1
Pharmacists should ensure they distinguish adjunctive treatments, such as nasal saline and decongestants, from main-line maintenance therapies, comprising antihistamines and intranasal steroids (INS). 1
The choice of INS can be influenced by a patient’s perceptions of a product’s characteristics such as scent, spray volume per actuation, or presence of phenyl-ethyl alcohol. 1
Managing patient expectations
The authors propose patients should be advised that while decongestants tend to be used for short-term symptom alleviation, INS and antihistamines are used for long-term symptom control, and that relief should not be expected immediately with INS. 1
Maximum symptom relief may occur several days after the start of INS treatment, and therefore patients should be advised not to stop treatment early. 1
Additionally, aspects of a current treatment that may result in an unwillingness to continue medication should be queried by the pharmacist, who could then assist patients in identifying possible alternatives. 1
By selecting the most effective agent to relieve the most troublesome symptoms, and managing a patient’s expectations of treatment, the pharmacist can help individual patients achieve optimal symptom control of AR. 1